**Introduction:** A 34 year old female, of Goan origin, with known Sjögren's syndrome presented one week post-partum with sudden onset of shortness of breath and haemoptysis. She was pyrexial and tachycardic with diffuse lung infiltrates on Chest X-Ray. She failed to respond to antibiotic treatment. CT scan showed ground glass changes and ECHO showed new Pulmonary Artery Hypertension. She commenced treatment with Steroids but arrested (PEA) and resuscitation failed.

**Case description:** Our patient was born in Goa but moved to England in 2001. In 2004 she presented acutely unwell with lymphadenopathy, basal lung consolidation and pyrexia of unknown origin. No specific cause was found and she returned to Goa for further investigation and treatment. She was told she had a 'collagen disorder' and was treated with a short course of oral steroids. This was tapered, she recovered and returned to the UK. In 2006 she conceived but had a miscarriage at 12 weeks gestation of uncertain aetiology. She conceived again in September 2006 but unfortunately the foetus was noted to have multiple abnormalities and she underwent an elective termination of pregnancy at 20 weeks in January 2007. An autoimmune screen at pregnancy booking was negative. Post pregnancy she developed multiple joint pains and Raynaud\'s and was referred for a Rheumatology opinion. At first rheumatology review in April 2007 we noted dystrophic nails with periungual erythema, tenderness in the joints but no synovitis. Blood pressure was normal and blood testing confirmed positive Rheumatoid factor, raised ESR (70 mm/hour) and C-reactive protein (29mg/l). She was anaemic (Hb 10.7, MCV 78). Repeat auto-immune testing confirmed that she was Ro positive, weakly RNP positive but double-stranded DNA negative. Anticardiolipin antibody was negative but she had an equivocal lupus anticoagulant which was negative on repeat. We recommended that any future pregnancy should be planned and closely monitored and it would be sensible for her to take Prophylactic Aspirin during pregnancy. We diagnosed her as Sjögren's/Lupus overlap with mild activity. We commenced her on Hydroxychloroquine 200mg bd for 6 weeks followed by once daily thereafter. By September 2007 she was well and denied any problems with a rash or joint pain. By January 2008, the patient had discontinued all medication herself as she felt well. She had decided that she would like to try for another baby and was referred to a specialist maternity clinic for pre-pregnancy counselling. However her marriage broke up and she did not pursue this. She remained well and off all medication until September 2010. She then complained of arthralgia and was noted to have some mild synovitis. Blood testing confirmed she was consistently Ro positive and double-stranded DNA negative. She had on-going hypergammaglobulinemia (26g/l) and moderate elevation of her ESR but a normal full blood count. We restarted Hydroxychloroquine and arranged on-going review. She did not start Hydroxychloroquine until September 2011 and then stopped it after only a few months. Blood testing confirmed negative double-stranded DNA, Ro positive and trace positive RNP. We encouraged her to continue with her Hydroxychloroquine and arranged a six month review. By April 2012 she was in a new relationship and was planning pregnancy. We recommended Folic Acid and Aspirin. In May 2013 she conceived and started the Folic Acid and Aspirin and referred her to the specialist pregnancy clinic. During the pregnancy she became anaemic (Haemoglobin 9, MCV). She also developed left carpal tunnel syndrome which responded to local steroid injection. She delivered successfully at term in February 2014. She failed to attend further rheumatology appointments until April 2015 by which time she was 23 weeks pregnant. She gave a history that a few weeks earlier she had become short of breath and was seen at the A&E Department. A pulmonary embolus was excluded, she was diagnosed with a probable chest infection and discharged home on antibiotics. Three days after starting the antibiotics, her face, mouth and tongue became swollen and she saw her GP who diagnosed a likely allergic reaction. She stopped the antibiotics and started antihistamines. Unfortunately the swelling then spread to involve her hands and feet. At rheumatology review she had oedema of the hands and feet. Blood pressure was low at 90/50. Her fundi were normal, her chest was clear. Blood testing from earlier that month had shown that her albumin had fallen to 29 g/l and her inflammatory markers were raised. Nephrotic syndrome was excluded. A 24 hour urine sample did not show proteinuria, chest x-ray was normal, her ECG showed sinus tachycardia. She was started on treatment dose Dalteparin whilst further investigations were undertaken. She had a lower limb ultrasound and a CTPA, neither of which showed any evidence of a pulmonary embolus. An abdominal ultrasound showed some mild splenomegaly. An Echocardiogram was reported as normal. Complement levels and immunoglobulins were normal. Her swelling improved during admission. She was mobile around the ward without any breathlessness. Observations were stable, she was afebrile and was discharged home on a few days later recovered. She delivered a healthy baby girl by caesarean section in July 2015 but was admitted acutely one week later with a 24 hour history of shortness of breath, cough and chest pain. On examination on admission she had no synovitis, no rash, and no oedema. The initial differential diagnosis was felt to include pneumonia or pulmonary embolus and TB was also considered. She started appropriate treatment with antibiotics and anticoagulation. Investigation confirmed high CRP and ESR with a reduced lymphocyte count. CXR showed diffuse lung infiltrates, CTPA showed no PE but ground glass changes. ECHO showed new moderate to severe pulmonary artery hypertension (PAH). Pelvic US excluded retained products of conception. She failed to settle with antibiotics and we started treatment with first oral and then pulsed IV steroids. Despite intensive medical input over the course of the next couple of days, she continued to deteriorate and suffered a PEA arrest. Resuscitation was unsuccessful. Post mortem showed alveolar haemorrhage, a small ASD, PAH changes and fatty liver.

**Discussion:** PAH is described in up to 10-20% of patients with Scleroderma, up to 10% in SLE but is rare in Sjögren's. In a cohort of 107 patients with Sjögren's a full prospective evaluation found evidence of mild to moderate PAH in 15% but no severe cases. Case reports suggest that PAH is often diagnosed late with low survival rates. There is an increased prevalence of PAH in patients with co-existent interstitial lung disease and an association with the presence of low complements, cryoglobulins and RNP antibodies. Pregnancy has an adverse effect on PAH -- the increased plasma volume and decreased systemic vascular resistance with high cardiac output worsening PAH. Our patient with clinically mild Sjögren's/lupus overlap had suffered 2 pregnancy losses followed by a successful pregnancy. In her 4th pregnancy she had an episode of SOB at 23 weeks gestation which resolved followed by the development of new PAH post-partum with catastrophic consequences.

**Key learning points:** Consider PAH in patients presenting with CTD acute SOB post-partum PAH is a rare, but potentially life threatening complication of CTD\'s including Sjögren's syndrome Pregnancy can worsen or precipitate PAH
